SCHEMBL9926890

SCHEMBL9926890

CCCCOc1ccc(C2(c3ccc(OC)cc3)C=Cc3c4c(c5ccccc5c3O2)-c2ccc(-c3ccccc3)cc2C4(C)O)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.33
PLA2G2A P14555 2/20 0.33
DHODH Q02127 1/20 0.33
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
GPR84 Q9NQS5 1/20 0.32
PTGS2 P35354 1/20 0.32
PTPN11 Q06124 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
PDE10A Q9Y233 1/20 0.31
PTGES O14684 1/20 0.31
ALOX5 P09917 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29565396 0.93 PDK2 (0.38) PDK2GPR84MEN1KMT2AEDNRB
SCHEMBL9926892 0.93 PDK2 (0.38) PDK2GPR84MEN1KMT2AEDNRB
SCHEMBL9900319 0.92 GAA (0.33) PDK2PLA2G2ADHODHFFAR1FFAR4
SCHEMBL9926891 0.91 GAA (0.33) PDK2PLA2G2ADHODHFFAR1FFAR4
SCHEMBL23604986 0.89 CYP2D6 (0.34) PLA2G2ADHODHPTPN11PTGESALOX5
SCHEMBL9926894 0.88 PDK2 (0.37) PDK2GPR84MEN1ALDH1A1LMNA
SCHEMBL29565411 0.88 PDK2 (0.37) PDK2GPR84MEN1ALDH1A1LMNA
SCHEMBL9900239 0.88 GAA (0.34) PLA2G2ADHODHFFAR1FFAR4GAA
SCHEMBL9926885 0.87 GAA (0.35) PLA2G2AFFAR1FFAR4GAAMAPT
SCHEMBL1823143 0.86 ALK (0.35) PDK2FFAR1FFAR4GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 US disclosed
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 US disclosed
WO-2013086248-A1 PHOTOCHROMIC MATERIALS THAT INCLUDE INDENO-FUSED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 2013-06-13 WO disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 US disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans NQO1, INTS6, IPO4 PDK2 1246/4885PLA2G2A 1829/4885DHODH 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.